期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 65, 期 11, 页码 7438-7475出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.2c00123
关键词
-
This article outlines the latest efforts and synthetic strategies in the development of peptidomimetic drugs, as well as their biological evaluation against a range of targets.
The use of peptides as therapeutics has often been associated with several drawbacks such as poor absorption, low stability to proteolytic digestion, and fast clearance. Peptidomimetics are developed by modifications of native peptides with the aim of obtaining molecules that are more suitable for clinical development and, for this reason, are widely used as tools in medicinal chemistry programs. The effort to disclose innovative peptidomimetic therapies is recurrent and constantly evolving as demonstrated by the new lead compounds in clinical trials. Synthetic strategies for the development of peptidomimetics have also been implemented with time. This perspective highlights some of the most recent efforts for the design and synthesis of peptidomimetic agents together with their biological evaluation toward a panel of targets.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据